Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

PURPOSE: Antipsychotic monotherapy is often recommended over antipsychotic polypharmacy because of fewer adverse events, reduced treatment complexity, and lower medication cost. This study compared the rate and the duration of antipsychotic monotherapy following initiation of olanzapine or risperido...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ye, Wenyu, Ascher-Svanum, Haya, Tanji, Yuka, Flynn, Jennifer A, Takahashi, Michihiro, Conley, Robert R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2012
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3385585/
https://ncbi.nlm.nih.gov/pubmed/22745559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S25662
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak